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Abstract
Introduction

We explored differences in Health-Related Quality of Life (HRQOL) and the youth's glycosylated
hemoglobin (A1c) of preadolescent and adolescent youths with type 1 diabetes (T1D) by individual
(age, sex, race) and family (socioeconomic status) factors, and associations between youths’ HRQOL,
their parents’ HRQOL, and youth's A1c.

Method

Correlational secondary analysis of baseline data from a randomized controlled trial testing a
developmental intervention for youths with T1D and their parents from two diabetes clinics.

Results

Better adolescent HRQOL was associated with better glycemic control. Better preadolescent HRQOL
was associated with better parent HRQOL. Non-White adolescents had worse HRQOL than White
adolescents; whereas Non-White preadolescents had worse glycemic control than White
preadolescents.

Discussion

Addressing HRQOL may promote better glycemic control in adolescents with T1D. For preadolescents
with T1D, parent HRQOL support may impact preadolescent HRQOL and improve glycemic control
moving into adolescence. Further study is warranted for non-White youths with T1D HRQOL and A1c
outcomes.
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INTRODUCTION

The risk of type 1 diabetes (T1D) in youths has been rising steadily since 2002 in White, Black, and
Hispanic youths, despite attempts to prevent, delay, or understand its etiology (Chiang et al., 2018).
This rise reflects a 21% overall increase in prevalence, and an adjusted risk for developing T1D of 1.4%
per year in the United States (Chiang et al., 2018). There are an estimated 98,200 youths aged less than
15 years who develop T1D worldwide, and it is estimated that the 600,900 youths aged less than 15
years will increase to 1.11 million in the next 20 years (Patterson et al., 2019). Sadly, this does not
include children diagnosed in less developed countries in which a lack of access to insulin results in
high case mortality (Patterson et al., 2019). Although there is a lower prevalence of T1D in Black youths
compared with White or Hispanic youths, the overall glycemic control of Black youths is significantly
and clinically worse than the glycemic control of either White or Hispanic youths (Foster et al.,
2019; Willi et al., 2015).
Unfortunately, in the United States, most youths with T1D do not meet goals for glycemic
control. Foster et al. (2019) identified that only 17% of 14,593 youths with T1D in the United States
met the national guidelines of a glycemic control that is reflected in a glycosylated hemoglobin (A1c)
blood test of less than 7.5% (58.5 mmol/mol). It should be noted that as of the 2018 international
guidelines, that goal was decreased to less than 7.0% (53 mmol/mol) for those with access to

comprehensive care (Mayer-Davis et al., 2018). Furthermore, 40% of youths with T1D have A1c tests
greater than 9% (75 mmol/mol), which is considered poor glycemic control (Chiang, Kirkman, Laffel,
Peters, & Type 1 Diabetes Sourcebook Authors, 2014; Wood et al., 2013). Poor glycemic control
contributes to acute short-term health outcomes (severe hypoglycemia, diabetic ketoacidosis; Foster
et al., 2019) and long-term complications (blindness, kidney failure, amputations; Jacobson et al.,
2013). Yearly per-child cost for a youth in the United States with T1D is estimated at $6,702.30 higher
than for a youth without T1D (Miller et al., 2016).
Health-related quality of life (HRQOL) is a measure of an individual's well-being with respect to their
physical health, general health status, worries about health, and the impact of a specific health
condition on physical, social, and emotional functioning (Hilliard et al., 2020). Anderson et al.
(2017) found an inverse relationship between HRQOL and glycemic control as measured by A1c, which
suggests its importance as an outcome measure concerning youths with T1D. Guidelines from the
American Diabetes Association and International Society of Pediatric and Adolescent Diabetes suggest
that HRQOL is an important parameter in the assessment and care of youths with T1D (American
Diabetes Association, 2020; Delamater et al., 2018). However, the assessment of HRQOL is rarely part
of routine diabetes clinical practice (Delamater et al., 2018). This may be due, in part, to provider
perceptions of the time needed for families to complete the measures and the difficulty in interpreting
and understanding how to use and/or apply these measures in a clinical setting (Myrvik et al., 2014).
Psychological support is necessary to promote effective coping and improved glycemic control, which
in turn can lead to improved quality of life (Pihoker et al., 2018). Using patient-reported outcome
measures, such as HRQOL, supports patient-centered care and must be further studied and
standardized in the clinical setting (Agiostratidou et al., 2017). Parent-proxy HRQOL has frequently
been used in research to measure HRQOL of youths but is not as accurate as self-report of youths and
adolescents (Yi-Frazier et al., 2016).
Assessing the HRQOL of parents of youths with chronic illness in research is emerging as a way to
assess and support the whole family of a youth with chronic illness (AlBuhairan et al., 2016; Grey, Jaser,
Whittemore, Jeon, & Lindemann, 2011; Jönsson, Lundqvist, Tiberg, & Hallström, 2015). WeissbergBenchell et al. (2009) found that family conflict related to diabetes and negative family communication
were associated with lower youth HRQOL, suggesting that interventions that target diabetes-specific
family interactions would benefit youth HRQOL. Some studies have tested family interventions of
youths with T1D that were successful in improving parent HRQOL, such as skill training, family
behavioral therapy, and training targeting family identified barriers to care (Fiallo-Scharer et al.,
2019; Grey et al., 2011; Kichler, Kaugars, Marik, Nabors, & Alemzadeh, 2013).
There are significant physical and psychological differences in preadolescent and adolescent youths
with T1D that could impact their health outcomes. Markowitz, Garvey and Laffel (2015) suggested that
youths aged less than 12 years want more independence but are not developmentally or cognitively
ready to care for their diabetes independently. This disparity results in families’ needing to provide
most of the diabetes care for preadolescents to adhere to the diabetes regimen (Markowitz et al.,
2015). In contrast, youths aged more than 12 years are cognitively ready to transition gradually to
providing most of their own care; however, most youths have glycemic control that deteriorates during
adolescence (Hilliard, Wu, Rausch, Dolan, & Hood, 2013b; Markowitz et al., 2015). Hilliard et al.

(2013b) suggested that some of these factors are modifiable, and some are not. Adolescents have
physical changes that cause insulin resistance (growth, hormonal shifts; Markowitz et al., 2015).
Adolescents also have psychosocial changes that impact their self-management, such as needing
independence, fitting in with friends, and higher risks for depression, to name a few (Iturralde,
Weissberg-Benchell, & Hood, 2017). Some of these developmental changes result in conflict with
parents that may result in barriers to parental involvement in adolescent diabetes cares (Markowitz et
al., 2015). Any of these factors could affect and/or lead to worse glycemic control (Chiang et al.,
2018; Markowitz et al., 2015).
Developmentally appropriate versions of the HRQOL measures exist for youths aged 8–12 years
(preadolescents) and youths aged 13–18 years (adolescents) with T1D. However, no studies were
found between 2000 and 2019 that explored differences in factors associated with HRQOL between
preadolescent and adolescent youths. Furthermore, no research was found that compared the HRQOL
of youths with T1D and the HRQOL of their parents.
Most of the youths with T1D in the United States do not meet national and international care goals,
and poor control of T1D affects youths’ physical health, HRQOL, and costs of care. To better
understand and support the developmental clinical outcomes of children with diabetes and their
families, evidence is needed regarding the differences in individual and family factors and HRQOL and
glycemic control of youths among different age groups. The availability of this evidence may assist in
efforts to target interventions to improve glycemic control and HRQOL.

Purpose of the Study

The purpose of this study was to explore the differences in HRQOL and A1c of preadolescent and
adolescent youths with T1D by individual (age, sex, race) and family (socioeconomic status [SES])
factors, and associations between youths’ HRQOL, their parents’ HRQOL, and youth's A1c.

Individual and Family Self-Management Theory

The selection of variables used in the design of this study was guided by the Individual and Family SelfManagement Theory (IFSMT; Ryan & Sawin, 2009). The IFSMT emphasizes the context (conditionspecific, physical and social environment, and individual and family risk and preventive factors),
processes, and proximal and distal outcomes of self-management in chronic illness (Ryan & Sawin,
2009). For this study, the contextual factors of interest are individual (age, sex, race) and family (SES),
with a primary focus on the developmental level of the child, defined in this study as preadolescent,
(age 8–12 years) or adolescent (age 13–16 years). The outcome data of interest are HRQOL and
glycemic control.

Hypotheses

We investigated the differences and associations of individual and family context factors with the
outcomes of glycemic control and HRQOL scores in preadolescent and adolescent youths with T1D.
Consistent with the IFSMT, we tested the following hypotheses.
1. There will be differences in the mean scores of glycemic control and HRQOL of preadolescents
and adolescents related to individual and family factors (age, sex, race, and SES).

2. HRQOL will be negatively correlated with glycemic control of preadolescents and adolescents;
higher HRQOL will be associated with lower A1c.
3. HRQOL of preadolescents and adolescents and their parent's HRQOL will be positively
correlated; higher youth HRQOL will be associated with higher parent HRQOL.

METHODS
Design

This study was a comparative and correlational secondary analysis of baseline data collected for the
“Impact of Family-Centered Tailoring of Pediatric Diabetes Self-Management Resources” study (FialloScharer et al., 2019). The current study used a subset of baseline data from the primary study collected
between September 2014 and May 2015.
The primary study evaluated the impact of developmentally appropriate, family-centered interventions
(understanding and organizing care, motivation, and family interactions). The interventions were
tailored to support family identified barriers to care. Youth glycemic control measured by A1c, youth
HRQOL, and parent HRQOL were also collected. The developmental interventions tested in the primary
study were effective in improving glycemic control in adolescents, but not preadolescents (FialloScharer et al., 2019).
The primary study was approved by the Institutional Review Board of the university, which was the
Institutional Review Board of record. This secondary analysis was deemed nonhuman subject research
by the university, because data were deidentified, and the researcher did not have access to the
patient-identified primary data.

Setting and Sample

The diagnosis of the youths took place at least 1 year before the primary study, and both parents and
children had to be willing to participate in the study. Youths were recruited from two pediatric
academic diabetes centers in the Midwestern United States (see Table 1 for demographics of youths
and parent participants). Exclusion criteria included the following: (1) cognitive or behavioral
impairments that would hinder participation in a group intervention, (2) non-English speaking, and (3)
less than 1 year after diagnosis with T1D. Eligible youths and their parents were approached to
consider participation by their care team while attending routine visits for standard diabetes care. The
goal of recruitment was 200 youth–parent dyads across both sites. Both youths and parents who
expressed interest in participating were assented and/or consented to participate in the study by
research coordinators. Youths were given age-appropriate assents.
TABLE 1. Sample characteristics
Characteristics
Age
Preadolescents, aged 8–12 years
Adolescents, aged 13–16 years
Sex
Male
Female

n

%

93
117

44.3
55.7

106
104

50.5
49.5

White
192
91.4
Preadolescent
88
95
Adolescent
104
89
Non-White
18
8.6
Preadolescent
5
5
Adolescent
13
11
SES: Private insurance
154
73.3
Preadolescent
67
72
Adolescent
87
74
SES: Public insurance
56
26.7
Preadolescent
26
28
Adolescent
30
26
Parent characteristics
210
100
Mother
181
84.6
White
188
87.9
Level of control
Goal A1c < 7.5%
14 (15) 25 (21)
Moderate A1c 7.5% to 8.5%
40 (43) 30 (26)
Poor A1c > 8.5%
39 (42) 62 (53)
Note. SES, socioeconomic status. International Society of Pediatric and Adolescent Diabetes (ISPAD)
target of less than 7.5 at the time of data collection.
Participants were youths aged 8–16 with T1D and their parent, guardian, and/or primary caretaker
(parent) dyad. For the current study, we separated the data by age group: preadolescent youths aged
8–12 years (n = 93) and adolescent youths aged 13–16 years (n = 117) to evaluate developmental
differences and associations as outlined in the hypotheses. Baseline data that contained complete data
on the variables of interest in the current study from the primary study sample were used to reveal
associations among the study variables as they were observed in usual care conditions before
involvement in the intervention.

Measures

Some baseline data from the primary study were collected via the iPad to enter into a secure research
database automatically. If paper versions of measures were used, or if data was abstracted from the
electronic health record (such as A1c), research assistants from the primary study hand-entered data
into the secure database. A new deidentified data set and the codebook was created for this secondary
analysis by the data manager of the primary study and provided to the first author of the current
study.

Individual and Family Context Variables

Individual variables included age, which was categorized as preadolescent (age 8–12 years) and
adolescent (age 13–16 years), sex (male, female), and race of the youth. Race was divided into two
groups. Non-White participants (including Non-Hispanic ethnicity) comprised Black, mixed, and other
races and represented 8.6% of total participants. White participants (including White-Hispanic
ethnicity) represented the remaining 91.4% of total participants. The family variable was SES, which

was measured using public and private insurance as a proxy. These demographic data were collected in
the primary study database.

A1c Test

The A1c test represents overall glycemic control. This test is the standard for tracking and predicting
risks of complications in patients with T1D based on the Diabetes Control and Complications Trial in
1993 (Sacks, 2012). For the primary study, A1c testing was standardized at both sites using a fingerstick
blood sample and the DCA Vantage (Siemens Medical Solutions Diagnostics, Erlangen, Germany). This
device meets the accepted performance criteria for A1c and exceeds some laboratory-based methods
(Lenters-Westra & Slingerland, 2014). A significant clinical difference in A1c test score results was
identified as 0.5% (Little, Rohlfing, Sacks, & National Glycohemoglobin Standardization Program (NGSP)
Steering Committee, 2011). These data were abstracted from the electronic medical record by
research assistants from the primary study and entered into the secure database.

Pediatric Quality of Life Inventory Diabetes Module

The 28-item Pediatric Quality of Life Inventory Diabetes Module (PedsQL-DM) was completed either by
an electronic tablet or paper by youths in the study. The PedsQL-DM was designed to measure HRQOL
dimensions tailored to pediatric diabetes (Varni, Burwinkle, & Seid, 2005). These age-specific measures
are developmentally appropriate, and the reliability and validity of these measures have been tested in
preadolescent and adolescent youths with T1D. In the current analysis, the Cronbach alpha coefficients
for preadolescents was α = 0.87, mean = 66.55, standard deviation (SD) = 12.65, and α = 0.91 for
adolescents, mean = 65.91, SD = 12.58. Hilliard et al. (2013a) identified the minimally important clinical
difference of the score as 5.27 for youth reports for participants with T1D taking the PedsQL-DM.

PedsQL Family Impact Module

The PedsQL Family Impact Module was developed to address the family impact of pediatric chronic
health conditions on the family (Varni, Sherman, Burwinkle, Dickinson, & Dixon, 2004). The PedsQL
Family Impact Module includes subscales; however, for this study, only the HRQOL portion was
analyzed and compared. The HRQOL portion of the PedsQL-FIM consists of the first three subscales of
the six subscales: (1) emotional functioning (5 items); (2) social functioning (4 items); (3)
communication (3 items). In the current analysis, the Cronbach alpha was α = 0.95 for the parent
HRQOL part of the PedsQL-FIM.

Data analysis

Youth and parent data were paired for the analysis using a linking code. All analyses of data were
performed using SPSS version 24 within the secure research platform. Independent sample t tests were
used to determine differences in the outcome variables (A1c and HRQOL) between dichotomized
context variables, with age, sex, race, and SES as the independent variables. Because of the uneven
group sizes in analyses of differences by race group, we used Welch t test that assumes unequal
variance. Associations between context and outcome variables were analyzed using Pearson
correlations (r). Preliminary analyses were performed to ensure there was no violation of the
assumptions of normality, linearity, and homoscedasticity of the continuous data. All the continuous
variables met these assumptions except the A1c, which was negatively skewed. Hemoglobin A1c values

were therefore log-transformed into a new variable named A1c Log (with a mean of 0.95 and SD of
0.08 [minimum of 0.76, maximum of 1.15]) for use in the correlation calculations.

RESULTS

Characteristics are displayed in Table 1. The sample consisted of 44.3% preadolescents and 55.5%
adolescents with nearly equal numbers of males and females. The sample was predominantly White
(n = 192, 91.4%), with only 8.6% of the sample non-White (Black = 7, multiracial = 7, Other [Hawaiian
and/or Pacific Islander, Native American, Asian] = 4). Rates of public insurance (the SES indicator) were
similar in preadolescents (28%) and adolescents (26%). The mean A1c of preadolescent youths was
8.77% (72.3 mmol/mol), SD = 1.52, and was not clinically or statistically different from the mean A1c of
the adolescent youths at 9.09% (75.8 mmol/ml), SD = 1.86 (difference of 0.14). In this sample, fewer
preadolescents than adolescents met the American Diabetes Association guidelines of A1c less than
7.5% (58.5 mmol/mol) 15% versus 21%, respectively.

Hypothesis 1

Results for the difference in HRQOL and A1c between preadolescent and adolescent youths for each of
the individual and family factors (age, sex, race, and SES) are displayed in Table 2. Race was the only
individual factor where significant differences were detected for both HRQOL and A1c.
TABLE 2. Differences in preadolescent and adolescent PedsQL-DM scores and glycemic control by
individual (age, sex, race) and family (SES)
Factor Outcome
Age
PedsQL-DM
Preadolescent
Adolescent
Glycemic control (A1c log)
Preadolescent
Adolescent
Sex
PedQL-DM
Preadolescent
Adolescent
Glycemic control (A1c log)
Preadolescent
Adolescent
Race
PedsQL-DM
Preadolescent
Adolescent
Glycemic control (A1c log)
Preadolescent
Adolescent
SES
PedsQL-DM
Preadolescent
Adolescent
Glycemic control (A1c log)

Mean (SD)

Test statistics p value
t(208) = 0.367
.714

66.55 (12.65)
65.91 (12.58)
0.94 (0.07)
0.95 (0.08)
Male
65.99 (12.62)
68.06 (11.95)
Male
0.93 (0.08)
0.96 (0.09)
White
66.97 (12.49)
66.88 (12.28)
White
0.93 (0.063)
0.95 (0.083)
Private insurance
67.80 (12.03)
66.36 (12.17)
Private insurance

Female
67.08 (12.79)
63.56 (12.95)
Female
0.94 (0.06)
0.94 (0.08)
Non-White
59.17 (14.75)
58.14 (12.66)
Non-White
1.05 (0.09)
0.99 (0.08)
Public insurance
63.31 (13.85)
64.58 (13.82)
Public insurance

t(208) = −1.210

.227

t(91) = −0.415
t(115) = 1.950

.679
.053

t(91) = −0.418
t(115) = 0.662

.677
.509

t(91) = −1.350
t(115) = −2.410

.307
.033

t(91) = 4.070
t(115) = 2.030

.036
.059

t(91) = 1.550
t(115) = 0.670

.153
.534

Preadolescent
0.93 (0.06)
0.96 (0.08)
t(91) = −1.960 .058
Adolescent
0.94 (0.08)
0.97 (0.09)
t(115) = −1.300 .225
Note. PedsQL-DM, Pediatric Quality of Life Inventory Diabetes Module; SES, socioeconomic status; SD,
standard deviation; A1c, glycosylated hemoglobin. Sample size of preadolescents (n = 93) and
adolescents (n = 117) was the same for all variables.
Non-White preadolescents had worse glycemic control (higher A1c) than White preadolescents
(p = .03). The difference between White and non-White adolescents’ HRQOL was statistically (p = .03)
and clinically significant, with a mean difference of 8.74 points, above the previously established
minimally important clinical difference of 5.27 points (Hilliard, et al. 2013a). Mean HRQOL of nonWhite preadolescents was lower by 7.80 points than White preadolescents, a finding that is clinically
but not statistically significant.
No other statistically significant differences were noted between preadolescents’ and adolescents’
HRQOL and A1c by age, sex, or SES. Male adolescents trended toward higher HRQOL than female
adolescents (p = .05), and preadolescents with private health insurance trended toward better
glycemic control (p = .06).

Hypothesis 2

Results of correlational analysis of the associations of HRQOL of preadolescents and adolescents and
their glycemic control are displayed in Table 3. Adolescent HRQOL scores, but not preadolescent
scores, were significantly negatively correlated (r = −.30, p = .001) with their glycemic control; higher
HRQOL was associated with lower A1c.
TABLE 3. Means and correlations of youth HRQOL with glycemic control and parent HRQOL
Youth HRQOL and glycemic control
n
Mean (SD)
Correlation (r)
p value
Preadolescent PedsQL-DM
93
66.55 (12.65)
−.190
.070
Preadolescent glycemic control (A1c log)
0.94 (0.07)
Adolescent PedsQL-DM
117 65.57 (12.58)
−.300
.001
Adolescent glycemic control (A1c log)
0.95 (0.08)
Youth and parent HRQOL
n
Mean (SD)
Correlation (r)
p value
Preadolescent PedsQL-DM
93
66.55 (12.65)
.333
.001
Parent PedsQL-FIM
62.37 (17.01)
Adolescent PedsQL-DM
117 65.57 (12.58)
.125
.181
Parent PedsQL-FIM
66.57 (16.21)
Note. HRQOL, Health-Related Quality of Life; SD, standard deviation; PedsQL-DM, Pediatric Quality of
Life Inventory Diabetes Module; A1c, glycosylated hemoglobin; PedsQL-FIM, Pediatric Quality of Life
Inventory Family Impact Module.

Hypothesis 3

Results of correlational analyses of the associations of HRQOL of preadolescents and adolescents with
the HRQOL of their parents are displayed in Table 3. Preadolescent HRQOL scores, but not adolescent
scores, were significantly correlated (r = .33, p = .001) with HRQOL scores of their parents.

DISCUSSION

The primary findings of this study are that individual factors of youths with T1D are associated with
glycemic control and HRQOL differently for preadolescents and adolescents. Non-White
preadolescents had worse glycemic control than their White counterparts. However, only non-White
adolescents had lower HRQOL than White adolescents. This contrast was also seen with the
relationships between age group, HRQOL, and A1c. Adolescent HRQOL was associated with their
glycemic control, and preadolescent HRQOL was not associated with their glycemic control.
Preadolescent HRQOL was associated with parent HRQOL, but adolescent HRQOL was not. These
findings demonstrate the complex relationships of age, race, HRQOL of both youths and parent, and
glycemic control.
Non-White youth had worse A1c outcomes than White youths. However, they comprised only 8.6% of
youths in this study; therefore, this difference must be interpreted with caution because of uneven
group sizes. This difference in group sizes by race is true of most studies of T1D, as there is a higher
incidence of T1D in non-Hispanic White youths than other races (Dabelea et al., 2014). The sample
composition in this study aligns with the finding of Willi et al. (2015), who reported that although Black
youths with T1D comprised 7% of a T1D registry of over 10,000 youths with T1D, those Black youths
had significantly worse mean glycemic control as measured by A1c test. In addition, Willi et al.
(2015) reported that both clinical outcomes and clinical management differed between the White and
Black youths, even when controlled by SES.
It should be noted that Black youths with T1D and either high or low SES were less likely to be treated
with insulin pumps or continuous glucose monitors than White or Hispanic youths with T1D with low
SES (Willi et al., 2015). These findings may reflect a complex pattern of systemic and/or implicit bias
affecting both clinical treatment and communication differences that Blair, Steiner, and Havranek
(2011) reported as common and persistent. Race is a social determinant of health (Alegria et al.,
2019; Trent, Dooley, & Dougé et al., 2019) associated with both psychological and cardiovascular stress
responses, which may lead to worse glycemic control (Sawyer, Major, Casad, Townsend, & Mendes,
2012).
HRQOL scores were significantly lower in non-White adolescents than in White adolescents.
Furthermore, the mean scores of non-White and White preadolescents were similar to those of the
adolescent race groups, but the difference did not reach statistical significance, possibly because of
uneven group size. One possible explanation is that non-White adolescents were more likely to have
worse glycemic control, which was associated with lower HRQOL in adolescents but not in
preadolescents. However, our inability to demonstrate racial and/or ethnic differences in HRQOL for
preadolescents may simply be due to the smaller sample size in the preadolescent group. Alegria et al.
(2019), in a longitudinal study of diverse youths, found a link between environment, discrimination,
and internalizing symptoms such as stress and anxiety. Research is needed to explore these important
health issues concerning race and health outcomes with a more balanced sample.
In preadolescents, glycemic control was not associated with HRQOL. This finding could be in part
because the parents of preadolescents with T1D are usually in charge of most of the daily diabetes
care. Developmentally, most youths with diabetes are ready to test their blood glucose when

approximately 8 years old, give insulin injections at approximately 10 years old, and do not have the
executive functions needed for complicated insulin to carbohydrate calculations until approximately 12
years old (Chien, Larson, Nakamura, & Lin, 2007; Markowitz et al., 2015). Subsequently, preadolescents
are not expected or able to drive the management of their diabetes care; therefore, preadolescents
may not consider their diabetes outcomes as part of their concern or within their control. The gradual
shift in care management from parents to youths as they move from later preadolescents to early
adolescents begins the transition to the autonomy of diabetes care (Iturralde et al., 2017). Adolescents
take on more and more of their diabetes care as they become older and, therefore, may feel more
connected with the outcomes of their care (Schilling, Knafl, & Grey, 2006).
In support of this interpretation of the findings, preadolescents’ HRQOL was moderately associated
with their parents’ HRQOL, whereas adolescents’ HRQOL was not associated with their parents’
HRQOL. The moderate association we identified between the quality of life of preadolescents and their
parents may be due to parents being more closely aligned, socially, and emotionally, with their
preadolescents’ lives and their diabetes management. In contrast, adolescent youths are more
independent in performing their care and spend more time away from their families. A possible
explanation of the lack of association between adolescent HRQOL and their parent's HRQOL may be
that adolescents are less likely to share their emotions and relationships with their parents. Therefore,
the parents of adolescents may not have that kind of information to incorporate into their quality of
life evaluation. In chronic illness, the necessary parental involvement in daily care can lead to
overprotection and overinvolvement of parents (Holmbeck et al., 2002). Overprotection and
overinvolvement of parents may result in the relationships between adolescents with chronic illness
and their parents to be more strongly affected by normal developmental shifts that occur during the
transition from preadolescence to adolescence (Holmbeck et al., 2002).
The finding that parental HRQOL was differently associated with preadolescents and adolescents was a
novel aspect of this study that may inform future intervention research. In addition, it may be
important to consider the assessment of HRQOL of parents in clinical care, to identify potential
psychosocial strengths and risks for support and referral. Assessment of parents may require more
integrated referral avenues between pediatric and adult health care systems to support identified
parent needs.

Limitations

The main disadvantage of using a secondary data set is that variables, subjects, and measurement tools
were selected for the primary study (Hulley, Cummings, Browner, Grady, & Newman, 2013; Polit &
Tatano, 2012). Other important variables to understanding the complexity of youth's diabetes
experience were not available for this secondary analysis. Variables such as depression, anxiety, and
youth and parent diabetes distress, as well as treatment variables (e.g., use of insulin pump or
continuous glucose monitoring, location of treatment [urban, rural]), might help to explain the
interrelationship of glycemic control and HRQOL.
Similar to most samples of youths with T1D, the current study had more White youths than Non-White
youths, especially in the United States; the sample did not have much diversity in either the
preadolescent or adolescent age groups (Dabelea et al., 2014). The percentage of White youths
(91.4%) was only slightly more than that of the White population (87.0%) of the state in which the

study was performed (United States Census Bureau, 2019). Although some of our data demonstrated
statistically significant associations of outcomes with race similar to those identified in larger samples
(Willi et al., 2015), they must be viewed with caution. Future studies with a more balanced sample are
warranted. Moreover, the sample was not sufficiently large to determine differences by age groups
within the non-White group.
SES was measured by private versus public insurance as a proxy measure. The use of other measures of
SES with larger samples may produce different results in future studies. Therefore, our results should
be considered cautiously within the constraints of the sample sizes and multiple analyses. Hemoglobin
A1c and HRQOL were measured concurrently, and therefore the directional effect of one on the other
cannot be determined, and no causal interpretation can be made from the findings. Future
interventional studies may be able to ascertain if a directional relationship exists between those
variables.

Implications for Clinical Practice

Glycemic control is an important aspect of outcomes in the care of youths with T1D. However,
identifying meaningful outcomes beyond glycemic control is important in holistic, person- and familycentered care (Angiostatidou et al., 2017). This study highlights some differences among youths as they
transition from preadolescence to adolescence, concerning associations between A1c and HRQOL and
associations between youth quality of life and parent HRQOL.
Health care providers and clinical teams should consider including patient-reported outcome
screening, such as the HRQOL, to examine the overall psychosocial health of youths and their families
affected by T1D. Psychosocial screening of quality of life, depression, diabetes distress, and social
determinants of health is recommended by national and international standards (ADA,
2020; Delamater et al., 2018). However, few pediatric diabetes practices incorporate these measures
into their clinical care (ADA, 2020; Delamater et al., 2018).
Teams caring for youths with T1D often include nurses, social workers, and psychologists who are well
suited to support the psychosocial health of youths with T1D and their families. As de Wit et al.
(2010) demonstrated, the benefits of assessing HRQOL and addressing implications of HRQOL in
adolescents were not sustained when the formal assessment was discontinued. Current work
by Hilliard et al. (2020) to develop a brief clinically validated tool for both preadolescents and
adolescents to assess HRQOL in the clinical setting is a promising addition. Although HRQOL is not the
only parameter of interest associated with outcomes of self-management, it continues to be an
important parameter to support overall health and well-being as well as the disease-specific outcome
of glycemic control. Future work integrating patient-reported outcome measures seamlessly into the
clinical workflow will be key for successful implementation of any patient-reported outcome measure
(Hilliard et al., 2018; Myrvik et al., 2014).
Evidence-based behavioral interventions have had success in promoting diabetes management in
children, adolescents, and families and should be tested in practice (Hilliard, Powell, & Anderson,
2016). These interventions include coping skills training (Grey, Boland, Davidson, Li, & Tamborlane,
2000; Grey et al, 2011), family interventions (Anderson, Brackett, Ho, & Laffel, 1999; Wysocki et al.,
2008), technology and mHealth interventions, and health care delivery system interventions (de Wit et

al., 2010). Community-based multisystemic interventions that integrate behavioral health care for
youths with T1D with chronically poor glycemic control may be an effective way to support care in
pediatric diabetes clinics as well (Hilliard et al., 2016).
The results of this study suggest supporting the HRQOL of parents of preadolescents may impact both
the parents’ coping and management of the child's cares, as well as the preadolescent glycemic
control. In adolescents with T1D, supporting their HRQOL may directly impact the coping and
management of their diabetes care and result in improved glycemic control. Improved emotional and
psychosocial health for those youths with poor glycemic control could result in fewer long-term
complications and costs of care due to decreased hospitalizations and emergency room visits. In
addition, the differences between preadolescent and adolescent relationships with their parents, as
well as between their HRQOL and their outcomes of care, are developmentally plausible and warrant
further investigation.
Differences in the glycemic control that we noted by race in our study may point to the need for
education of the entire health care team on implicit bias, systemic bias, and perhaps the long-term
effects of environment or trauma on patients and their families. By increasing team awareness of the
potential for implicit bias or other effects of race as a social determinant, the team may be able to
implement strategies that lead to increased communication and trust with all families.

CONCLUSIONS

The daily care required to manage T1D is complex and continuous for the youth's lifetime. Parent,
youth, and family relationships are impacted by daily care demands. Care strategies must address
individual and family factors to encompass a broader perspective beyond physical symptoms and
laboratory tests. To improve physical and emotional care outcomes and reduce long-term
complications and cost of T1D, research-based interventions to support increased quality of life of both
youths and their parents should be considered as part of the standard care for families that are
affected with T1D.
Non-White preadolescent youths with T1D may need special attention to address their increased risk
for poor glycemic control. Addressing issues related to the adolescent quality of life is one strategy to
promote better glycemic control and should be a standard component of adolescent diabetes care. For
preadolescents, addressing issues that impact their parents’ quality of life issues may positively impact
the preadolescent's own quality of life, setting the stage for better glycemic control as they transition
into adolescence. Further exploration of patients, their families, and their providers’ perceptions
associated with the use of patient-related outcome measures in routine care clinical settings will be
important to assess their acceptance of using patient-reported outcome measures to improve care and
collaboration in care and outcomes.
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